GLAUKOS Corp GKOS

Latest FY: 2025 Healthcare Medical Devices
Market Price $180.29
Market Cap $10.59B
P/E Ratio N/A
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↑32.3% YoY
$507.44M
3-Yr CAGR: 21.5%
Net Income ↓-28.2% YoY
-$187.69M
Net Margin: -37.0%
Free Cash Flow ↑66.8% YoY
-$22.45M
FCF Yield: -0.21%
EPS (Diluted) ↓-18.4% YoY
$-3.28
Basic: $-3.28
Return on Equity Efficiency
-28.6%
ROA: -21.0%

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (GKOS)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Div / Sh Div Yield Op. Cash Flow Free Cash Flow FCF YoY
FY 2016 $114.4M $98.2M $4.5M $0.12 0.00% $12.3M $6.0M
FY 2017 $159.3M +39.2% $138.2M $-0.1M -102.0% -100.0% 0.00% $25.5M $19.2M +218.3%
FY 2018 $181.3M +13.8% $156.2M $-13.0M -13,977.2% $-0.37 0.00% $18.9M $8.5M -55.5%
FY 2019 $237.0M +30.7% $198.4M $15.4M +219.1% $0.37 +200.0% 0.00% $-0.4M $-5.1M -159.6%
FY 2020 $225.0M -5.1% $133.2M $-120.3M -880.3% $-2.70 -829.7% 0.00% $-23.0M $-29.9M -487.5%
FY 2021 $294.0M +30.7% $227.4M $-49.6M +58.8% $-1.07 +60.4% 0.00% $24.7M $-23.1M +22.9%
FY 2022 $282.9M -3.8% $213.9M $-99.2M -100.0% $-2.09 -95.3% 0.00% $-33.1M $-63.3M -174.5%
FY 2023 $314.7M +11.3% $239.1M $-134.7M -35.8% $-2.78 -33.0% 0.00% $-57.8M $-78.0M -23.1%
FY 2024 $383.5M +21.9% $289.5M $-146.4M -8.7% $-2.77 +0.4% 0.00% $-61.3M $-67.6M +13.3%
FY 2025 $507.4M +32.3% $282.8M $-187.7M -28.2% $-3.28 -18.4% 0.00% $-14.8M $-22.5M +66.8%
$

Valuation

Market Price $180.29
Market Cap $10.59B
Enterprise Value $10.50B
P/E Ratio N/A
P/B Ratio 16.14
FCF Yield -0.21%
Dividend Yield N/A
Shares Outstanding 58,733,900
%

Profitability & Margins

Gross Margin 55.72%
Operating Margin -39.33%
Net Margin -36.99%
Return on Equity (ROE) -28.60%
Return on Assets (ROA) -21.01%
Asset Turnover 0.57x
Revenue 3-Yr CAGR 21.51%
🛡️

Financial Health & Liquidity

Current Ratio 4.69
Cash Ratio 0.90
Debt / Equity 0.000
Debt / Assets 0.000
Cash & Equivalents $90.81M
Total Debt N/A
Book Value / Share $11.17
💧

Cash Flow Efficiency

Operating Cash Flow -$14.79M
Capital Expenditures (CapEx) $7.67M
Free Cash Flow -$22.45M
OCF / Revenue -2.91%
FCF / Revenue -4.43%
FCF 3-Yr CAGR N/A
🏷️

Per Share Metrics

EPS (Diluted) $-3.28
EPS (Basic) $-3.28
Dividends / Share N/A
Book Value / Share $11.17
EPS YoY Growth -18.41%
🏛️

Balance Sheet (FY 2025)

Total Assets $893.49M
Total Liabilities $237.33M
Stockholders' Equity $656.15M
Current Assets $474.98M
Current Liabilities $101.28M